Maho Ishikawa
Saitama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Thiamine deficiency observed in family caregivers of AYA cancer patients.
Journal: Palliative & supportive care
Published: July 20, 2026
Reattempt of tyrosine kinase inhibitor discontinuation after maintenance therapy with ponatinib in patients with chronic myeloid leukaemia in the chronic phase: Result of the Japan Adult Leukemia Study Group RE-STOP219 study.
Journal: British journal of haematology
Published: March 12, 2026
Development of a blood test-based predictive scoring tool for treatment response in chronic myeloid leukemia.
Journal: International journal of hematology
Published: September 03, 2025
Mantle cell lymphoma exhibiting repeated progression with the initiation of a JAK-1 inhibitor for psoriatic arthritis.
Journal: International journal of hematology
Published: June 19, 2025
The incidence of vascular adverse events and usefulness of novel risk assessment tool in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.
Journal: Cardio-oncology (London, England)
Published: February 13, 2025
Four timing patterns of initiation of advance care planning discussions as practiced by home visiting nurses: A qualitative study.
Journal: Journal of general and family medicine
Published: July 30, 2024
Effective treatment of relapsed/refractory CD19-positive B/T-type mixed-phenotype acute leukemia with blinatumomab: A case report.
Journal: EJHaem
Published: March 19, 2024
Successful treatment with sequential blinatumomab/ponatinib in a patient with chronic myeloid leukemia presenting with a CD19-positive mixed phenotype blast phase
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: January 01, 2024
Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study Group.
Journal: International journal of hematology
Published: October 19, 2023
Thoracic SMARCA4-deficient undifferentiated tumor resembling malignant lymphoma
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: April 30, 2023
Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice.
Journal: Internal medicine (Tokyo, Japan)
Published: April 02, 2023
Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide.
Journal: Cancer immunology, immunotherapy : CII
Published: February 07, 2023
Last Updated: 09/26/2026